Question 1

Am I eligible for this trial based on my current medications and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia clinical trial (NCT00089869). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of olanzapine and atomoxetine compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia clinical trial (NCT00089869). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia clinical trial (NCT00089869). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia clinical trial (NCT00089869). Contact the study team or your healthcare provider for specific answers.

Question 5

What would happen if I experienced side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia clinical trial (NCT00089869). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia clinical trial (NCT00089869). Contact the study team or your healthcare provider for specific answers.

What this study is about